2011-11-15T17:01:00
FINANCE: Slippage on capital expenditure due to the delay on the renal scheme remains outside of the 25 per cent tolerance level that Monitor applies to capital spend variances.
With a HSJ subscription you’ll unlock:
Already a subscriber? Sign into your account here
Part of HSJ Information Ltd. The White Chapel Building, 1st Floor, 10 Whitechapel High Street, London, E1 8QS. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud